HK$9.33
0.11%
Hong Kong, Sep 25, 04:08 pm HKT. Closed.
ISIN
HK1093012172
Symbol
1093
Index

CSPC Pharmaceutical Group Limited Stock price

HK$9.33
-0.08 0.85% 1M
+0.84 9.89% 6M
+0.90 10.68% YTD
+0.03 0.32% 1Y
+3.62 63.40% 3Y
-0.31 3.22% 5Y
+5.23 127.33% 10Y
+8.83 1,766.00% 20Y
Hong Kong, Closing price Fri, Sep 25 2026
-0.01 0.11%
ISIN
HK1093012172
Symbol
1093
Index
Industry

AI Insights on CSPC Pharmaceutical Group Limited Insights AI Insights on CSPC Pharmaceutical Group Limited

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is CSPC Pharmaceutical Group Limited a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$107.4b
Enterprise Value
HK$86.5b
Net debt
positive
Cash
HK$21.7b
Shares outstanding
11.5b
Valuation (TTM | estimate)
P/E
12.3
P/S
2.9 | 2.8
EV/Sales
2.4 | 2.3
EV/FCF
-
P/B
2.4
Dividends
DPS
HK$0.33
Yield 1Y | 5Y
3.5% | 3.4%
Growth 1Y | 5Y
37.5% | 14.2%
Payout 1Y | 3Y
82.5% | 61.7%
Increased
1 Year
Financials (TTM | estimate)
Revenue
HK$36.6b | HK$38.4b
EBITDA
-
EBIT
HK$10.5b
Net Income
HK$8.7b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
20.5% | 26.4%
EBITDA
-
EBIT
81.9%
Net Income
92.7%
Free Cash Flow
-
Margin
Gross
71.9%
EBITDA
-
EBIT
28.8%
Net
23.7%
Free Cash Flow
-
Financial Health
Equity Ratio
71.1%
Return on Equity
11.7%
ROCE
21.7%
ROIC
32.6%
Debt/Equity
0.0
More
EPS
HK$0.8
FCF per Share
-
Short interest
-
Employees
20k
Rev per Employee
HK$1.5m

CSPC Pharmaceutical Group Limited Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a CSPC Pharmaceutical Group Limited forecast:

23x Buy
79%
4x Hold
14%
2x Sell
7%

Analyst Opinions

29 Analysts have issued a CSPC Pharmaceutical Group Limited forecast:

Buy
79%
Hold
14%
Sell
7%

Financial data from CSPC Pharmaceutical Group Limited

Jun '26
+/-
%
36,601 36,601
20% 20%
100%
- Direct Costs 10,303 10,303
2% 2%
28%
26,299 26,299
30% 30%
72%
- Selling and Administrative Expenses 8,887 8,887
2% 2%
24%
- Research and Development Expense 7,192 7,192
15% 15%
20%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 10,539 10,539
82% 82%
29%
Net Profit 8,679 8,679
93% 93%
24%

In millions HKD.

Don't miss a Thing! We will send you all news about CSPC Pharmaceutical Group Limited directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Hong Kong.

Head office Hong Kong
CEO Mr. Zhang
Employees 19,700
Founded 1997
Website www.cspc.com.hk

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today